Identification of First Trimester Serum Biomarkers for Prediction of Gestational Diabetes Mellitus

Read full text Summarise with VIRAT
Authors: Salah Abusnana, Salam T. Alshammaa, Bashair M. Mussa, Mohsin Sulaiman
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Gestational diabetes mellitus (GDM) is glucose intolerance first recognized in the second or third trimester, affecting 10 to 14% of pregnancies worldwide per ADA and IADPSG criteria. GDM increases risks for mothers and infants, including preeclampsia and future type 2 diabetes. Traditional risk prediction relies on maternal factors such as age, prepregnancy BMI, and family history. Recent studies suggest serum proteins—IL-6, High Molecular Weight Adiponectin, and hs-CRP—may serve as early pregnancy biomarkers for GDM. Few studies exist in the Middle East, and none in the United Arab Emirates (UAE). Objective: This study aims to evaluate these biomarkers in the UAE for first-trimester GDM prediction. Methods: A prospective cohort study collected samples from 73 pregnant women (

Fields of Study & Subjects

Gestational Diabetes Research and Management Pregnancy and preeclampsia studies Diabetes Cardiovascular Risks and Lipoproteins

Publication details

Journal / source
Ibnosina Journal of Medicine and Biomedical Sciences
Volume
18
Publication date
1 March 2026
Language
EN